Cobalamin and cobalamin-binding proteins in plasma related to the clinical condition in chronic myelogenous leukemia

Drug response prediction in high-risk multiple myeloma.

Gene·2017

Demonstrated Benefit of Continuous Interferon-Alpha-2b Therapy in Hairy Cell Leukemia. A Two-Year Follow-Up.

Leukemia & lymphoma·2016

Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation.

International journal of laboratory hematology·2016

Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial.

Bone marrow transplantation·2015

The role of epigenetics in the biology of multiple myeloma.

Blood cancer journal·2014

Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⁻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma.

Scandinavian journal of immunology·2010

Predicting long-term survival in primary myelofibrosis.

Leukemia·2026

Targeting the mitochondrial complex I subunit NDUFS2 potentiates FLT3 inhibition in acute myeloid leukaemia with FLT3 internal tandem duplication.

Leukemia·2026

Targeting the eIF4F translation initiation complex disrupts BCR::ABL1 translation and overcomes drug resistance in CML.

Leukemia·2026

Neoantigenic receptor ROR1 promotes cell growth through diverse and complementary mechanisms.

Leukemia·2026

Inhibition of PHB2/PINK1-mediated mitophagy potentiates venetoclax activity in acute myeloid leukemia.

Leukemia·2026

Combating CD24 to overcome CD19 CAR-T resistance via induction of innate and adaptive immunity in B-cell malignancies.

Leukemia·2026

Body Composition Phenotypes and Their Metabolic Associations in Treatment-Naïve Patients With Newly Diagnosed Type 2 Diabetes: A DXA-Based Cluster Analysis.

Endocrinology, diabetes & metabolism·2026

Late-onset cobalamin C defect with a rare MMACHC c.457 C > T variant: a case report and literature review.

BMC pediatrics·2026

Impact of DBLG1 Hybrid Closed-Loop Software Optimization and Meal Declaration Pattern on Glucose Metrics in Type 1 Diabetes: A 12-Month Prospective Evaluation in 2014 Users.

Diabetes, obesity & metabolism·2026

Association between central sensitization inventory and taste alterations in patients with burning mouth syndrome: a cross-sectional study.

Journal of oral & facial pain and headache·2026

Total healthcare costs and cost savings after bariatric surgery and glucagon-like peptide-1 receptor agonist treatment for obesity and diabetes vary with insurance coverage.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery·2026

A new indicator of cobalamin deficiency.

Practical laboratory medicine·2026

Related Experiment Videos

Cobalamin and cobalamin-binding proteins in plasma related to the clinical condition in chronic myelogenous leukemia

Related Concept Videos

Drug response prediction in high-risk multiple myeloma.

Demonstrated Benefit of Continuous Interferon-Alpha-2b Therapy in Hairy Cell Leukemia. A Two-Year Follow-Up.

Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation.

Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial.

The role of epigenetics in the biology of multiple myeloma.

Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⁻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma.

Predicting long-term survival in primary myelofibrosis.

Targeting the mitochondrial complex I subunit NDUFS2 potentiates FLT3 inhibition in acute myeloid leukaemia with FLT3 internal tandem duplication.

Targeting the eIF4F translation initiation complex disrupts BCR::ABL1 translation and overcomes drug resistance in CML.

Neoantigenic receptor ROR1 promotes cell growth through diverse and complementary mechanisms.

Inhibition of PHB2/PINK1-mediated mitophagy potentiates venetoclax activity in acute myeloid leukemia.

Combating CD24 to overcome CD19 CAR-T resistance via induction of innate and adaptive immunity in B-cell malignancies.

Body Composition Phenotypes and Their Metabolic Associations in Treatment-Naïve Patients With Newly Diagnosed Type 2 Diabetes: A DXA-Based Cluster Analysis.

Late-onset cobalamin C defect with a rare MMACHC c.457 C > T variant: a case report and literature review.

Impact of DBLG1 Hybrid Closed-Loop Software Optimization and Meal Declaration Pattern on Glucose Metrics in Type 1 Diabetes: A 12-Month Prospective Evaluation in 2014 Users.

Association between central sensitization inventory and taste alterations in patients with burning mouth syndrome: a cross-sectional study.

Total healthcare costs and cost savings after bariatric surgery and glucagon-like peptide-1 receptor agonist treatment for obesity and diabetes vary with insurance coverage.

A new indicator of cobalamin deficiency.

Related Experiment Videos

Cobalamin and cobalamin-binding proteins in plasma related to the clinical condition in chronic myelogenous leukemia

Related Concept Videos

Related Articles